ABSTRACT Blot hybridization analysis indicated that NIH 3T3 mouse cells transformed by high molecular weight DNAs of a human bladder and a human lung carcinoma cell line contained new sequences homologous, respectively, to the transforming genes of Harvey (rasH) and Kirsten (rasK) sarcoma viruses. The unique ras sequences were present in multiple independent NIH cell lines transformed in both primary and secondary transfection assays and corresponded to ras sequences normally present in human DNAs. The ras gene product was expressed in NIH cells transformed by bladder carcinoma DNAs and in the human bladder carcinoma cell lines at levels 2-to 4-fold greater than the level observed in nontransformed NIH 3T3 cells. These results indicate that the transforming genes of these human tumor cell lines are the cellular homologs of two retroviral transforming genes.
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Transfection of cellular DNAs has demonstrated that both normal and transformed cells contain genes capable of inducing oncogenic transformation (1, 2) . DNAs ofa variety ofneoplasms from several different vertebrate species, including man, induce transformation of NIH 3T3 cells with high efficiencies, indicating that carcinogenesis can involve dominant genetic alterations resulting in the activation of cellular transforming genes (3) (4) (5) (6) (7) (8) (9) (10) . Analysis of the transforming genes activated in neoplasms has suggested that different transforming genes are activated in different types ofneoplasms, but the same or closely related transforming genes are activated in independent neoplasms of the same type of differentiated cells (6-8, 10, 11) .
One class of potential cellular transforming genes is composed of the cellular homologs of the transforming genes of highly oncogenic retroviruses. These viruses contain specific genes that are responsible for transformation and that are homologous to genes ofnormal cells (12) . At least a dozen different viral transforming genes have been identified, each of which has a cellular homolog (13) . These cellular sequences are highly conserved in vertebrate evolution, but their function in both normal and neoplastic cells has been unclear.
In the present study, we have investigated the possible relationship between the cellular homologs of retroviral transforming genes and the transforming genes detected by transfection of tumor DNAs. We report here that the transforming genes of human bladder and lung carcinoma cell lines are homologous to the transforming genes of Harvey and Kirsten sarcoma viruses. (18) . Prehybridization, hybridization, and washing procedures were as described by Hanahan and Meselson (19) except that 10% dextran sulfate was included in the hybridization buffer (20) .
MATERIALS AND METHODS

Cell
p21 Immunoprecipitation. The procedure used was a modification of that previously described (21 (21) . Cell lysates were then incubated for 1 hr at 4°C with 50 ,ul of staphylococcal protein A-Sepharose (50% suspension) that had been precoated with rabbit anti-rat immunoglobulin G. The protein A-Sepharose was removed by centrifugation and lysates were incubated for 1.5 hr at 40C with rat monoclonal antibody 259 against Harvey sarcoma virus p21 (generously provided by E. M. Scolnick). This monoclonal antibody recognizes broadly reactive p21 determinants which are present on cellencoded, rasH-encoded, and rasK-encoded gene products (M.
Furth and E. M. Scolnick, personal communication). Lysates were then incubated for an additional 1.5 hr at 40C with 50 ,ul ofa 50% suspension ofprotein A-Sepharose precoated with rabbit anti-rat immunoglobulin G. Immune precipitates were collected by centrifugation, washed, and analyzed by electrophoresis in sodium dodecyl sulfate/polyacrylamide gels as described (21) . The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
of viral transforming genes were used as probes for hybridization to Southern (22) blots of DNAs of NIH cells transformed by DNAs of a variety of neoplasms. Fig. 1 illustrates results of a representative analysis in which BamHI-digested DNAs were hybridized with 32P-labeled DNA of a plasmid containing the transforming gene (rasH) of Harvey sarcoma virus. DNAs of NIH 3T3 cells and NIH cells transformed by DNAs of human lung and mammary carcinomas and several human lymphoid neoplasms contained only a 3.4-kb BamHI fragment that represents the normal mouse rasH gene (Fig. 1, lanes a and c-h ) (23) . In contrast, DNA of NIH cells transformed by DNA of the EJ human bladder carcinoma cell line contained an additional 6.6-kb BamHI fragment that was not present in NIH 3T3 DNA (Fig. 1, lane i) . This 6.6-kb rasH-containing BamHI fragment was also detected in DNAs of two additional independent NIH cell lines transformed by EJ bladder carcinoma DNA (lanes j and k) and in DNAs of two independent NIH cell lines transformed in secondary transfection assays by 10-to 15-kb fragments of DNA of NIH cells transformed by EJ bladder carcinoma DNA (lanes 1 and m) . The presence of the 6.6-kb rasH_ containing BamHI fragment in DNAs of three independent primary and two independent secondary lines of transformed NIH cells indicates that transformation by EJ bladder carcinoma DNA was mediated by transfer of these rasH sequences.
The 6.6-kb rasH-containing BamHI fragment was also present in DNA of NIH cells transformed by DNA of a second human bladder carcinoma cell line, J82 (Fig. 1, lane n) . However it is presently unclear whether or not this cell line is distinct from EJ or from a third bladder carcinoma cell line, T24, which also possesses transforming activity (8) .
BamHI digestion ofhuman DNAs yielded two rasH -containing fragments (Fig. 1, lane b) (15) . Only the normal mouse rasK-containing EcoRI Expression ofras Gene Products in Bladder Carcinomas and Transformed NIH Cells. The rasH and rasK genes encode related 21,000-dalton proteins designated p21 (15 The p21 doublet was not detected in controls that lacked anti-p21 monoclonal antibody.
analyzed for p21 expression by immunoprecipitation with a broadly reactive rat monoclonal antibody against Harvey sarcoma virus-encoded p21. A representative analysis is shown in Fig. 3 . The background observed in these gels is similar to that reported by others (25 (2) and with molecular clones of the normal cell genes homologous to the transforming genes of Moloney sarcoma virus (mos) (27) and to rasH (28) have indicated that altered expression of normal cell genes can result in transformation. In addition, abnormal expression of the cellular homolog of the transforming gene (myc) of avian myelocytomatosis virus has been implicated in the development ofchicken B cell lymphomas (29, 30) .
Although molecular clones of the normal rat rasH genes lack transforming activity, recombination of these genes with virdl transcriptional regulatory sequences results in activation of transforming activity that is correlated with an increased level ofgene expression (28) . It is thus possible that the transforming activity of ras genes in the human bladder and lung carcinomas is a consequence of mutations in regulatory sequences that result in abnormal gene expression. Alternatively, activation of the transforming activity ofthese genes in tumors may involve mutations affecting the activity of the gene products.
These results provide a link between the transforming genes of viruses and human neoplastic disease. The findings that the cellular homologs of the transforming genes of two sarcoma viruses induce efficient transformation upon transfection of DNAs of two human carcinoma cell lines and that the protein encoded by these genes is expressed in both transformed NIH 3T3 cells and the original human tumor cell lines strongly suggests a causal role for these genes in human bladder and lung carcinomas.
Because the rasH and rasK genes are members of a family of related human genes (15), the involvement of two different members of this gene family in human bladder and lung carcinomas further suggests the possibility that these genes may be involved in a variety of human neoplasms ofepithelial origin.
If this is the case, further studies of these genes and their gene products may contribute to understanding the etiology of a significant class of human tumors.
